TC
MDT icon

Titleist Capital’s Medtronic MDT Stock Holding History

Titleist Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$460K Sell
5,923
-156
-3% -$12.6K 0.11% 145
2022
Q3 		$491K Buy
+6,079
New +$546K 0.11% 136
2022
Q2 		– Sell
-2,262
Closed -$251K – 263
2022
Q1 		$251K Sell
2,262
-192
-8% -$20.3K 0.05% 224
2021
Q4 		$254K Buy
+2,454
New +$284K 0.05% 198

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Titleist Capital's MDT Position: Q4 2022 in Review

Titleist Capital reduced its Medtronic (MDT) stake by 2.6% in Q4 2022, selling an estimated $12.6K and leaving 5,923 shares worth $460K. The position accounts for 0.11% of the portfolio, ranked #145.

Titleist Capital first reported a position in MDT in Q4 2021 and has held it in 4 quarters since. The position peaked at $491K in Q3 2022. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • Titleist Capital held 5,923 shares of Medtronic worth $460K as of Q4 2022.
  • Titleist Capital sold 156 Medtronic shares in Q4 2022, an estimated $12.6K.
  • Medtronic made up 0.11% of Titleist Capital's portfolio in Q4 2022, its #145 holding.
  • Titleist Capital first reported a position in Medtronic in Q4 2021 and has held it in 4 quarters since.
  • Titleist Capital's Medtronic position peaked at $491K in Q3 2022.
  • 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.